期刊文献+

维持性血液透析合并尿路上皮癌患者临床特点及危险因素分析(附11例报告) 被引量:4

The clinical features of urothelial carcinoma and its related factors in patients with maintenance hemodialysis(Report of 11 cases)
原文传递
导出
摘要 目的:探讨维持性血液透析(MHD)患者易合并尿路上皮癌的相关因素、临床诊治特点及预后。方法:回顾性分析我院2005年3月~2009年4月收治的387例MHD患者中并发尿路上皮癌的11例患者临床资料,调查其尿路上皮癌的发生情况、临床诊治特点及预后,分析影响尿路上皮癌发生的危险因素。结果:11例MHD合并尿路上皮癌的临床特点均表现为间断、无痛性肉眼血尿及不同程度的贫血,其中透析龄超过5年者8例,超过3年者2例,15个月者1例。11例均行手术治疗,至今生存6~48个月,平均27.2个月,已有3例死亡,余未见肿瘤复发。Logistic回归分析结果显示透析龄是尿路上皮癌发生的独立危险因素。结论:维持性血液透析患者易合并尿路上皮癌,且透析龄是并发尿路上皮癌的危险因素,早期手术治疗有助于改善预后。 Objective:To investigate the urothelial carcinoma and its related factors, clinical features and prog nosis in patients on maintenance dialysis. Method:We recruited 387 maintenance hemodialysis patients into a study, to investigate the incidence of urothelial carcinoma and the clinical features of the malignancies. We also used logis tic regression analysis method to analyze the tumor-related factors. Result: Among the 387 maintenance hemodialysis patients, l 1 eases(2.84%) developed urothelial carcinoma. All of the patients with urothelial carcinoma presented intermittent and painless gross hematuria and exhibited refractory anemia. This group includes 8 cases with hemodialysis more than 5 years, more than 3 year: 2 cases, there was 1 case with hemodialysis in 15 monthes. All of the patients with urothelial carcinoma were treated with surgery. Whose survival time has been lasted for 6 to 48 months (average 27.2 months). Three of them died, others have survive with no recurrence. Logistic regres sion analysis showed that age and the time of dialysis was the independent risk factors relating to urothelial carcinoma. Conclusion:The incidence of urothelial carcinoma was high in maintenance hemodialysis patients, the time of dialysis was an independent risk factors relating to urothelial carcinoma. Early diagnosis and operation are essential to improve their prognosis.
出处 《临床泌尿外科杂志》 2012年第10期750-752,755,共4页 Journal of Clinical Urology
关键词 维持性血液透析 尿路上皮癌 临床特点 危险因素 maintenance hemodialysis urothelial carcinoma clinical features hazards
  • 相关文献

参考文献16

  • 1STEWART J, BUCCIANTI G, AGOGOA L, et al. Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealan[J]. J Am Soc Nephrol, 2003,14:197-- 207.
  • 2MAISONNEUVE P, AGODOA L, GELLERT R, et al. Cancer in patients on dialysis for end-stage renal disease: an international collaborative study[J].Lan- cet, 1999, 354:93--99.
  • 3MATAS A J, SIMMONS R L, KJELLSTRAND C M, et al. Increased incidence of malignancy during chronic renal failur[J]. Lancet, 1975, 1 : 883-- 886.
  • 4CHEN K S, LAI M K, HUANG C C, et al. Urolog- ic cancers inuremic patients[J]. Am J Kidney dis, 1995, 25:694--700.
  • 5TSENG S F, CHUANG Y C, YANG W C. Long- term outcome or radical cystectomy in ESDR patients with bladder urothelial carcinoma[J].Int Urol Neph- rol, 2011, 43:1067--1071.
  • 6CHANGCH, YANGCM, YANGAH. Renal di- agnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwa[J]. Canc- er, 2007, 109:1487--1492.
  • 7KANG C H, CHEN C H, CHIANG P H. Primary urothelial carcinoma of the upper urinary tract in dial- ysis patients with 5-year follow-up[J].Jpn J Clin On- col, 2010, 40:241--246.
  • 8WUCF, CHANGPL, CHENCS, etal. The out- come of patients on dialysis with upper urinary tract transitional cell carcinoma[J].J Urol, 2006, 176: 477-481.
  • 9CHUNG S D, HUANG K H, LAI M K, et al. CKD risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma[J].Am J Kidney Dis, 2007, 50: 743-- 753.
  • 10SATOH S, TSUCHIYA N, HABUCHI T, et al. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis [J]. J Urol, 2005, 174:1749-1753.

二级参考文献25

  • 1Excerpts from United States Renal Data System 1999.Annual data report[J].Am J Kidney Dis,1999,34[Suppl]:S1-S176.
  • 2Tsakiris D,Jones EHP,Briggs D,et al.Death within 90 days from starting renal replacement therapy in the ERA-EDTA Registry between 1990 and 1992[J].Nephrol Dial Transplant,1999,14:2343-2350.
  • 3Acosta J,Hettings J,Fluckiger R et al.Molecular basis for a link between complement and the vascular complications of diabetes[J].Proc Natl Acad Sci USA,2000,97:5450-5455.
  • 4Panichi V,Miglio M,De Pietro S et al.The link of biocompatibility to cytokine production[J].Kidney Int 2000; 58:S96-S103.
  • 5Lagrand WK,Cees A,Visser CA et al.C-reactive protein as a cardiovascular risk:more than an epiphenomenon[J]? Circulation,1999,100:96-102.
  • 6Zoccali C,Tripepi G,Mallamaci F.Dissecting Inflammation in ESRD:Do Cytokines and C-Reactive Protein Have a Complementary Prognostic Value for Mortality in Dialysis Patients[J]? J Am Soc Nephrol,2006,17(12_suppl_3):S169-S173.
  • 7Calvani M,Benatti P,Mancinelli A,et al.Carnitine replacement in endstage renal disease and hemodialysis[J].Ann N YAcad Sci,2004,1033:52-66.
  • 8Girndt M,Sester M,Sester U,et al.Molecular aspects of T-and B-cells in uremia[J].Kidney Int,2000,59[Suppl 78]:S206-S211.
  • 9Eleftheriadis T,Spaia S,Patsalas S,et al.Aortic stiffness in patients undergoing hemodialysis is positively related to antigen presenting celldependent T-lymphocyte reactivity[J].Ren Fail,2006,28(1):63-68.
  • 10Sester U,Sester M,Hauk M,et al.T-cell activation follows Thl rather than Th2 pattern in haemodialysed patients[J].Nephrol Dial Transplant,2000,15:1217-1223.

共引文献153

同被引文献58

  • 1郭彦聪,徐艳春,王小月.维持性血液透析患者并发结核9例回顾性分析[J].中国血液净化,2005,4(9):484-486. 被引量:7
  • 2OU JH,PAN CC,LIN JS,et al.Transitional cell carcinoma in dialysis patients[J].Eur Urol,2000,37(1):90-94.
  • 3WU CF,SHEE JJ,HO DR,et al.Different treatment strategies for end stage renal disease in patients with transitional cell carcinoma[J].J Urol,2004,171(1):126-129.
  • 4MAISONNEUVE P,AGODOA L,GELLERT R,et al.Cancer in patients on dialysis for endstage renal disease:an international collaborative study[J].Lancet,1999,354(9173):93-99.
  • 5MATAS AJ,SIMMONS RL,KJELLSTRAND CM,et al.Increased incidence of malignancy during chronic renal failure[J].Lancet,1975,1(7912):883-886.
  • 6LIN HF,LI YH,WANG CH,et al.Increased risk of cancer in chronic dialysis patients:a populationbased cohort study in Taiwan[J].Nephrol Dial Transplant,2012,27(4):1585-1590.
  • 7ZHANG Y,ZHU C,CURADO MP,et al.Changing patterns of bladder cancer in the USA:evidence of heterogeneous disease[J].BJU Int,2012,109(1):52-56.
  • 8WU CF,PANG ST,SHEE JJ,et al.Identification of genetic alterations in upper urinary tract urothelial carcinoma in endstage renal disease patients[J].Genes Chromosomes Cancer,2010,49(10):928-934..
  • 9YOSSEPOWITCH O,SAGY I,MARGEL D,BANIEL J.Urothelial carcinoma of the bladder in patients on hemodialysis:Clinical characteristics and oncological outcomes[J].J Urol,2012,187(4):1215-1219.
  • 10TSENG SF,CHUANG YC,YANG WC.Longterm outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma[J].Int Urol Nephrol,2011,43(4):1067-1071.

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部